Black, C M <br/><br/>
Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study.  [electronic resource] 

 -  British journal of rheumatology  Sep 1998 
 - 952-60 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0263-7103 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/37.9.952  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Iloprost--administration & dosage<br/>Male<br/>Middle Aged<br/>Raynaud Disease--classification<br/>Scleroderma, Systemic--complications<br/>Treatment Outcome<br/>Vasodilator Agents--administration & dosage